Bavarian Nordic (OTCMKTS:BVNRY) Stock Crosses Below 50 Day Moving Average – Here’s What Happened

Bavarian Nordic (OTCMKTS:BVNRY) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $9.54 and traded as low as $9.07. Bavarian Nordic shares last traded at $9.33, with a volume of 4,138 shares traded.

Bavarian Nordic Stock Down 1.4%

The firm has a 50 day simple moving average of $9.54 and a 200-day simple moving average of $9.86. The company has a market cap of $2.22 billion, a PE ratio of 12.31 and a beta of 1.20.

Bavarian Nordic (OTCMKTS:BVNRY) last released its quarterly earnings results on Wednesday, May 13th. The company reported $0.01 EPS for the quarter. Bavarian Nordic had a net margin of 19.74% and a return on equity of 9.32%. The business had revenue of $165.70 million during the quarter.

About Bavarian Nordic

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.